An Lu

Beijing Key Laboratory Of Molecular Pharmaceutics And New Drug Delivery Systems, State Key Laboratory Of Natural And Biomimetic Drugs
Beijing, 100191, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Nintedanib-amplified effects of HSP47 siRNA on liver fibrosis therapy by inhibiting collagen secretion.

Nintedanib-amplified effects of HSP47 siRNA on liver fibrosis therapy by inhibiting collagen secretion.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: July 29, 2025

Enhanced Tumor Immunotherapy by Triple Amplification Effects of Nanomedicine on the STING Signaling Pathway in Dendritic Cells.

Enhanced Tumor Immunotherapy by Triple Amplification Effects of Nanomedicine on the STING Signaling Pathway in Dendritic Cells.

Journal: Advanced healthcare materials

Published: August 21, 2024

Natural endogenous material-based vehicles for delivery of macromolecular drugs.

Natural endogenous material-based vehicles for delivery of macromolecular drugs.

Journal: Chinese journal of natural medicines

Published: August 18, 2024

Lipid Nanoparticular Codelivery System for Enhanced Antitumor Effects by Ferroptosis-Apoptosis Synergistic with Programmed Cell Death-Ligand 1 Downregulation.

Lipid Nanoparticular Codelivery System for Enhanced Antitumor Effects by Ferroptosis-Apoptosis Synergistic with Programmed Cell Death-Ligand 1 Downregulation.

Journal: ACS nano

Published: June 13, 2024

Nanomedicines Promote Cartilage Regeneration in Osteoarthritis by Synergistically Enhancing Chondrogenesis of Mesenchymal Stem Cells and Regulating Inflammatory Environment.

Nanomedicines Promote Cartilage Regeneration in Osteoarthritis by Synergistically Enhancing Chondrogenesis of Mesenchymal Stem Cells and Regulating Inflammatory Environment.

Journal: ACS nano

Published: March 07, 2024

Lipid core-shell nanoparticles co-deliver FOLFOX regimen and siPD-L1 for synergistic targeted cancer treatment.

Lipid core-shell nanoparticles co-deliver FOLFOX regimen and siPD-L1 for synergistic targeted cancer treatment.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: November 22, 2023

Nanomedicines Reprogram Synovial Macrophages by Scavenging Nitric Oxide and Silencing CA9 in Progressive Osteoarthritis.

Nanomedicines Reprogram Synovial Macrophages by Scavenging Nitric Oxide and Silencing CA9 in Progressive Osteoarthritis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 28, 2022

Ionic Liquids: Promising Approach for Oral Drug Delivery.

Ionic Liquids: Promising Approach for Oral Drug Delivery.

Journal: Pharmaceutical research

Published: February 16, 2022

Non-viral vectors for RNA delivery.

Non-viral vectors for RNA delivery.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: October 30, 2021

A review of existing strategies for designing long-acting parenteral formulations: Focus on underlying mechanisms, and future perspectives.

A review of existing strategies for designing long-acting parenteral formulations: Focus on underlying mechanisms, and future perspectives.

Journal: Acta pharmaceutica Sinica. B

Published: January 06, 2021

Showing 1-10 of 10

Last Updated: 09/26/2026